United States Coronary Artery Bypass Surgery (CABG) Diabetes Project (USCDP) Pilot Study
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Standard care for patients with diabetes having CABG surgery at Providence St. Vincent
Medical Center includes strict control of blood sugar (glucose) levels for 3 days after
surgery. This is done through frequent monitoring of blood sugar levels and by giving insulin
continuously through a needle into a vein (intravenously). This intensive glucose control has
resulted in fewer complications such as serious infections and death, and has shortened the
length of the hospital stay for patients.
This study treatment is different from standard treatment in that it extends the intensive
glucose control beyond the third postoperative day to one full year. Once discharged from the
hospital following the CABG procedure, the intense glucose control is done using subcutaneous
insulin (a shot under the skin), oral medications, and by measuring blood sugar levels
frequently.
The purpose of this study is to see how safe and effective strict glucose control is when
extended beyond 3 days and hospital discharge for one year. Another purpose is to see how
well patients can comply with the daily management of intensive glucose control for one-year
as well as the study follow-up schedule.